Results 251 to 260 of about 62,013 (267)

Infliximab

Reactions Weekly, 2009
openaire   +2 more sources

Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease

Gut, 2007
Séverine Vermeire, Geert D'Haens
exaly  

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort

Gut, 2009
M Ferrante, Ingrid Arijs, Kristel Van Steen   +2 more
exaly  

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

Gut, 2015
, Séverine Vermeire
exaly  

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

The Lancet Gastroenterology and Hepatology, 2017
Cyriel Y Ponsioen, Ailsa L Hart, Rogier M P H Crolla   +2 more
exaly  

The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab

Gut, 2014
B Ungar, Michal Y Chowers, Uri Kopylov
exaly  

Infliximab

Reactions Weekly, 2015
openaire   +2 more sources

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

Gut, 2009
M Ferrante, Séverine Vermeire
exaly  

Infliximab

Reactions Weekly, 2014
openaire   +1 more source

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

New England Journal of Medicine, 2010
Gerassimos J Mantzaris, Geert D'Haens
exaly